Towards Healthcare
Oncology Drug Discovery Market Size and Top Companies Analysis

Oncology Drug Discovery Market Growth and AI Adoption Analysis

According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development of innovative cancer treatments.

Content

  • Insight Code: 5786
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The oncology drug discovery market is expected to witness strong growth from 2024 to 2034, fueled by the rising cancer burden, advances in precision medicine, and the adoption of AI and genomic technologies.

North America is currently leading the healthcare cybersecurity market due to its high concentration of clinical trials and strong collaboration between academia, biotech startups, and government agencies.

The oncology drug discovery market includes 5 segments by component, by therapy, by cancer type, by stage of development, by modality, and by region.

Some key players include Roche, Merck, Johnson &Johnson, Dr. Reddys, and Sanofi.

Key trends include the growth due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies.

It typically takes 10–15 years from discovery to regulatory approval, though accelerated pathways and innovative approaches are reducing timelines.

AI accelerates drug discovery by analyzing complex datasets, predicting drug-target interactions, and identifying biomarkers, thereby shortening timelines and reducing costs.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions